The Medezin factory has started production in a 7R Park Lodz West I in Konstantynow Lodzki. This is the second brand belonging to the Pelion group, which operates in 7R Park Lodz West I. The storage area for Medezin was designed in the BTS formula and was adapted to the specific needs of the pharmaceutical…
Orpea Polska, one of the largest players on the geriatric care market in Poland, will launch a new nursing home. It will be located in Piaseczno near Warsaw and will operate under the Orpea Rezydencje brand. New nursing home with nearly 150 places The centre in Piaseczno near Warsaw has 144 beds in single and…
The Polish network of clinical trials centres – Pratia, a member of the Neuca Group, has acquired a 40% stake in the German KFGN. It is a company operating on the clinical research centres market. Ultimately, Neuca will acquire 100% of shares. KFGN: Over 700 clinical trials KFGN has been operating on the clinical trials…
Many interesting things happened on the market in 2019 and undoubtedly had an impact on the private healthcare market in Poland. As Artur Bialkowski, member of the Management Board of Medicover sp. z o.o., managing director for business services, says in an interview with PMR, for the first time in years governmental and public institutions…
Robert Neymann will remain president of Bioton for another 3-year term, the company announced in a communiqué. The resolution of the Supervisory Board shall come into force on the date of expiry of the previous term of office, i.e. 16 May. Robert Neymann has international experience in global FMCG corporations and biotechnology companies. For over…
Several dozen pharmacies of the Super-Pharm chain in Israel will sell medical marijuana products manufactured by IM Cannabis Corporation (IMC). This is the result of a three-year distribution agreement signed between Focus Medical Herbs and the pharmacy chain. The distribution agreement was signed in mid-April. Under the agreement, Focus Medical will sell a total of…
A few days ago we reported that the NFZ had reduced the valuation of coronavirus tests. As it turns out, the valuation proposed by the NFZ results from the analysis of the Agency for Health Technology Assessment and Evaluation (AOTMiT). AOTMiT has collected data from dozens of laboratories According to the new NFZ valuation, the…
Due to the fact that a large part of the population is asymptomatic in COVID-19, the actual scale of the disease in individual countries is difficult to estimate. It is, according to different estimates, several dozen or even several hundred times higher than the number of infected people diagnosed with molecular tests. Therefore, the UK…
In accordance with the order of the President of the National Health Fund (NFZ), the valuation of molecular tests for coronavirus was reduced to PLN 280. The order came into force on the day of its announcement, i.e. 21 April. This is not the first change in test conditions and pricing The billing product “SARS-CoV-2…
Nearly 1/3 of coronavirus infections in Poland come from hospitals or clinics. Another 7% are Social Welfare Houses (DPS), the Chief Sanitary Inspectorate (GIS) informed. Mazowieckie is an outbreak of hospital-acquired infections Coronavirus infections in hospitals and outpatient clinics affect both patients and medical staff in these facilities. It is worth noting that nearly half…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.